 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.             *hb0209*      
HOUSE BILL 209  
J1, J3    6lr1633  
HB 95/25 – HGO  (PRE –FILED)    
By: Delegate Allen  
Requested: October 31, 2025  
Introduced and read first time: January 14, 2026  
Assigned to: Health  
 
A BILL ENTITLED  
 
AN ACT concerning  1 
 
Health Care Providers – Assisted Reproductive Treatment – Informed Consent 2 
and Fraud  3 
 
FOR the purpose of prohibiting a health care provider from using the health care provider’s 4 
human reproductive material when providing assiste d reproductive treatment 5 
without the consent of the recipient of the treatment; prohibiting a health care 6 
provider from using a donor’s  human  reproductive material to provide assisted 7 
reproductive treatment witho ut the donor’s informed consent or in a manner that is 8 
inconsistent with the donor’s consent; requiring a health care provider to obtain 9 
certain informed consent before providing assist ed reproductive treatment; 10 
prohibiting a health care provider and an em ployee of a health care provider from 11 
misrepresenting certain information regarding human reproductive material or the 12 
donor of the material to the recipient of an assisted reproductive treatment; and 13 
generally relating to assisted reproductive treatment a nd health care provider fraud.  14 
 
BY adding to  15 
 Article – Health – General  16 
Section 20 –112 17 
 Annotated Code of Maryland  18 
 (2023 Replacement Volume and 202 5 Supplement)  19 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 20 
That the Laws of Maryland read as follows:  21 
 
Article – Health – General  22 
 
20–112. 23 
 
2 HOUSE BILL 209   
 
  (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 1 
INDICATED . 2 
 
  (2) (I) “ASSISTED REPRODUCTIVE  TREATMENT ” MEANS A METHOD 3 
OF CAUSING PREGNANCY  OTHER THAN THROUGH S EXUAL INTERCOURSE . 4 
 
   (II) “ASSISTED REPRODUCTIVE  TREATMENT ” INCLUDES : 5 
 
    1. DONATION OF EGGS OR S PERM ; 6 
 
    2. DONATION OF EMBRYOS ; 7 
 
    3. INTRACYTOPLASMIC SPER M INJECTION ; 8 
 
    4. INTRAUTERINE OR INTRA CERVICAL INSEMINATIO N; 9 
AND 10 
 
    5. IN VITRO FERTILIZATIO N AND EMBRYO TRANSFER . 11 
 
  (3) “DONOR” MEANS AN INDIVIDUAL WHO PROVIDES , WITH OR 12 
WITHOUT CONSIDERATIO N, SPERM OR AN OVUM INT ENDED FOR USE IN ASS ISTED 13 
REPRODUCTIVE TREATME NT. 14 
 
  (4) “HEALTH CARE PROVIDER ” MEANS AN INDIVIDUAL WHO IS 15 
LICENSED , CERTIFIED , OR OTHERWISE AUTHO RIZED UNDER THE HEALTH 16 
OCCUPATIONS ARTICLE TO PROVIDE AS SISTED REPRODUCTIVE TREATMENT . 17 
 
  (5) “HUMAN REPRODUCTIVE MA TERIAL” MEANS : 18 
 
   (I) A HUMAN SPERMATOZOON ; 19 
 
   (II) A HUMAN OVUM ; OR 20 
 
   (III) A HUMAN ORGANISM AT AN Y STAGE OF DEVELOPME NT 21 
FROM FERTILIZE D OVUM TO EMBRYO . 22 
 
  (6) “INFORMED CONSENT ” MEANS A WRITTEN DOCU MENT THAT : 23 
 
   (I) IS SIGNED BY THE PATI ENT; AND 24 
 
   (II) IS ATTESTED TO BY THE  PATIENT ’S TREATING HEALTH 25 
CARE PROVIDER AND A WITNESS . 26 
 
 HOUSE BILL 209  3 
 
  (B) BEFORE PROVIDING AN A SSISTED REPRODUCTIVE  TREATMENT , A 1 
HEALTH CARE PROVIDER  SHALL : 2 
 
  (1) OBTAIN A DONOR ’S WRITTEN CONSENT TO  USE THE DONOR ’S 3 
HUMAN REPRODUCTIVE MATERIA L; 4 
 
  (2) OBTAIN A RECIPIENT ’S CONSENT TO USE A S PECIFIC DONOR ’S 5 
HUMAN REPRODUCTIVE MATERIA L; 6 
 
  (3) ENSURE THAT CONSENT F OR THE USE OF HUM AN REPRODUCTIVE 7 
MATERIAL IS PROVIDED  ON A FORM THAT IS DI STINCT AND SEPARATE FROM ANY 8 
OTHER CONSENT FORM ; AND 9 
 
  (4) MAINTAIN A COPY OF WR ITTEN CONSENT OBTAIN ED UNDER ITEM 10 
(1) OR (2) OF THIS SUBSECTION I N THE PROVIDER ’S PATIENT RECORDS . 11 
 
 (C) (1) A HEALTH CARE PROVIDER SHALL : 12 
 
   (I) USE HUMAN REPRODUCTIV E MATERIAL FROM A DO NOR 13 
WITH THE RECIPIENT ’S INFORMED CONSENT T O USE THAT DONOR ’S HUMAN  14 
REPRODUCTIVE MATERIA L DURING ASSISTED RE PRODUCTIVE TREATMENT ; 15 
 
   (II) USE A DONOR ’S HUMAN REPRODUCTIVE  MATERIAL FOR 16 
ASSISTED REPRODUCTIVE  TREATMENT : 17 
 
    1. WITH THE DONOR ’S INFORMED CONSENT ; AND 18 
 
    2. IN A MANNER THAT IS C ONSISTENT WITH THE 19 
DONOR’S INFORMED CONSENT ; 20 
 
   (III) INFORM THE RECIPIENT OF ANY MISUSE , 21 
MISREPRESENTATION , OR ERROR INVOLVING T HE HUMAN REPRODUCTIVE 22 
MATERIAL USED IN THE  ASSISTED REPRODUCTIV E TREATMENT ; AND 23 
 
   (IV) REPORT MISUSE , MISREPRESENTATION , OR ERROR 24 
INVOLVING THE HUMAN REPRODUCTIVE MATERIA L USED IN THE ASSIST ED 25 
REPRODUCTIVE TREATME NT TO THE HEALTH CAR E PROVIDER ’S LICENSING BOARD . 26 
 
  (2) A HEALTH CARE PROVIDER  MAY NOT : 27 
 
   (I) INTENTIONALLY OR KNOW INGLY PROVIDE ASSIST ED 28 
REPRODUCTIVE TREATME NT TO A PATIENT USIN G THE HEALTH CARE PR OVIDER’S 29 
SPERM OR OVUM WITHOU T THE PATIENT ’S INFORMED CONSENT T O ASSISTED 30 
4 HOUSE BILL 209   
 
 REPRODUCTIVE TREATME NT USING TH E HEALTH CARE PROVID ER’S SPERM OR 1 
OVUM ; OR 2 
 
   (II) PROVIDE ASSISTED REPR ODUCTIVE TREATMENT U SING A 3 
DONOR’S SPERM OR OVUM IF T HE HEALTH CARE PROVI DER KNOWS OR REASONA BLY 4 
SHOULD KNOW THAT THE  HUMAN REPRODUCTIVE M ATERIAL WAS USED : 5 
 
    1. WITHOUT THE DONOR ’S CONSENT ; OR 6 
 
    2. IN A MANNER INCONSIST ENT WITH THE DONOR ’S 7 
CONSENT . 8 
 
  (3) A HEALTH CARE PROVIDER  OR AN EMPLOYEE OF A HEALTH CARE 9 
PROVIDER WHO HANDLES  HUMAN REPRODUCTIVE M ATERIAL MAY NOT : 10 
 
   (I) MISREPRESENT THE QUAL ITY OF THE HUMAN 11 
REPRODUCTIVE MATERIAL TO THE RECI PIENT OF AN ASSISTED  REPRODUCTIVE 12 
TREATMENT ; OR 13 
 
   (II) MISREPRESENT ANY INFO RMATION ABOUT THE DO NOR’S 14 
IDENTITY , GENETIC CHARACTERIST ICS, OR MEDICAL HISTORY T O THE RECIPIENT 15 
OF AN ASSISTED REPRO DUCTIVE TREATMENT . 16 
 
 (D) (1) A HEALTH CAR E PROVIDER WHO VIOLA TES SUBSECTION (C)(2)( I) 17 
OF THIS SECTION IS L IABLE FOR CIVIL DAMA GES IN AN ACTION BRO UGHT BY : 18 
 
   (I) THE WOMAN WHO GIVES B IRTH TO A CHILD AFTE R 19 
RECEIVING THE ASSIST ED REPRODUCTIVE TREA TMENT ; 20 
 
   (II) THE SPOUSE OR DOMESTI C PARTNER OF T HE WOMAN WHO 21 
GIVES BIRTH TO A CHI LD AFTER RECEIVING T HE ASSISTED REPRODUC TIVE 22 
TREATMENT ; OR 23 
 
   (III) THE CHILD BORN AS A R ESULT OF THE ASSISTE D 24 
REPRODUCTIVE TREATME NT. 25 
 
  (2) A HEALTH CARE PROVIDER  WHO VIOLATES SUBSECT ION (C)(2)( II) 26 
OF THIS SECTION IS L IABLE FOR CIVIL DAMAGE S IN AN ACTION BROUG HT BY A 27 
DONOR WHOSE HUMAN REPRODUCTIVE MATERIA L WAS USED BY THE HE ALTH CARE 28 
PROVIDER FOR ASSISTED REPRODUCTIVE TREATME NT WITHOUT THE DONOR ’S 29 
CONSENT OR NOT IN CO MPLIANCE WITH THE DO NOR’S CONSENT . 30 
 
 HOUSE BILL 209  5 
 
   (3) AN INDIVIDUAL  WHO BRINGS AN ACTION  UNDER THIS SECTION 1 
MAY ASSERT A SEPARAT E CAUSE OF ACTION : 2 
 
   (I) FOR A VIOLATION OF SU BSECTION (C)(2)( I) OF THIS 3 
SECTION , FOR EACH CHILD BORN AS THE RESULT OF THE  ASSISTED REPRODUCTIV E 4 
TREATMENT ; AND 5 
 
   (II) FOR A VIOLATION OF SU BSE CTION (C)(2)( II) OF THIS 6 
SECTION , FOR EACH INDIVIDUAL WHO RECEIVED ASSISTE D REPRODUCTIVE 7 
TREATMENT WITH THE D ONOR’S HUMAN REPRODUCTIVE  MATERIAL . 8 
 
  (4) A CHILD BORN AS A RESU LT OF ASSISTED REPRO DUCTIVE 9 
TREATMENT PROVIDED B Y A HEALTH CARE PROV IDER IN VIOLAT ION OF 10 
SUBSECTION (C)(2)( I) OF THIS SECTION IS E NTITLED TO A QUALIFI ED PROTECTIVE 11 
ORDER ALLOWING THE C HILD ACCESS TO THE P ERSONAL MEDICAL RECO RDS AND 12 
HEALTH HISTORY OF TH E HEALTH CARE PROVID ER. 13 
 
  (5) A CIVIL ACTION UNDER T HIS SECTION SHALL BE  FILED : 14 
 
   (I) WITHIN 10 YEARS AFTER THE CHIL D BORN AS A RESULT O F 15 
THE ASSISTED REPRODU CTIVE TREATMENT REAC HES THE AGE OF 18 YEARS ; 16 
 
   (II) WITHIN 20 YEARS AFTER THE DAY ON WHICH THE ASSISTE D 17 
REPRODUCTIVE TREATME NT WAS PROVIDED ; OR 18 
 
   (III) WITHIN 2 YEARS AFTER THE DAY ON WHICH AN INDI VIDUAL 19 
FIRST DISCOVERS SUFF ICIENT EVIDENCE THRO UGH DNA  ANALYSIS THAT THE 20 
INDIVIDUAL HAS A CAU SE OF ACTION AGAINST  A HEALTH CARE PROVID ER UNDER 21 
THIS SECTION . 22 
 
  (6) A PLAINTIFF WHO PREVAI LS IN AN ACTION BROU GHT UNDER THIS 23 
SECTION SHALL B E ENTITLED TO : 24 
 
   (I) FOR AN ACTION BROUGHT  UNDER SUBSECTION (C)(2)( I) OF 25 
THIS SECTION , THE COSTS OF THE ASS ISTED REPRODUCTIVE T REATMENT ; 26 
 
   (II) LIQUIDATED DAMAGES NO T TO EXCEED $50,000;  27 
 
   (III) COMPENSATORY DAMAGES ; AND 28 
 
   (IV) REASONABLE ATTORNEY ’S FEES AND COSTS . 29 
 
6 HOUSE BILL 209   
 
  (E) (1) A HEALTH CARE PROVIDER  MAY NOT INTENTIONALL Y OR 1 
KNOWINGLY PROVIDE AS SISTED REPRODUCTIVE TREATMENT TO A PATIE NT USING 2 
THE HEALTH CARE PROV IDER’S SPERMATOZOON OR OV UM WITHOUT THE PATIE NT’S 3 
INFORMED CONSENT TO ASSISTED REPRODUCTIV E TREATMENT USING THE HEALTH 4 
CARE PROVIDER ’S SPERMATOZOON OR OV UM. 5 
 
  (2) A PERSON WHO VIOLATES PARAGRAPH (1) OF THIS SUBSECTION 6 
IS GUILTY OF A FELON Y AND ON CONVICTION IS SUBJECT TO IMPRIS ONMENT NOT 7 
EXCEEDING 10 YEARS OR A FINE NOT EXCEEDING $5,000  OR BOTH . 8 
 
 (F) THIS SECTION MAY NOT BE CONSTRUED TO PROH IBIT A PERSON FROM 9 
PURSUING ANY OTHER R EMEDY PROVIDED BY LA W. 10 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 11 
October 1, 202 6. 12 
 